samedan logo
 
 
 
spacer
home > pmps > autumn 2020 > the fight against plastic pollution
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Fight Against Plastic Pollution

The complex challenges of plastic pollution have been looming over the pharmaceutical industry for a number of years. Following a series of highprofile documentaries focusing on the growing occurrences of plastic being found in our oceans, this issue has never been more front-of-mind to a mainstream audience. Now, as the world looks towards the use of PPE, the spotlight appears to be back on pharma companies and what changes they can make to stop the spread of plastics contaminating oceans.

Plastic (Not-So) Fantastic

Plastic has an important role to play in the pharma industry. While in some industries it forms part of unnecessary packaging, there is no denying that it has functional properties for pharma companies. Whether part of protective packaging for pills, such as paracetamol, or through respiratory items like inhalers, its role and importance in this sector has grown over the years.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
With over 30 years’ experience working for, and with, leading global manufacturers, retailers, and associated supply chain organisations, Kimberly Carey Coffin is a Global Technical Director for Supply Chain Assurance at Lloyd’s Register.

An experienced and recognised sustainability expert, Dave Garforth is part of a senior leadership team of standards and certification professionals who founded the Responsible Plastic Management Program.

John Hamill is a Respiratory/Diabetic Specialist Independent Prescribing GP Pharmacist and Pharmaceutical Associate of the Responsible Plastic Management Program.
spacer
Kimberly Carey Coffin
spacer
spacer
spacer
Dave Garforth
spacer
spacer
spacer
John Hamill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Luina Bio Announces New Bio-Manufacturing GMP And Development Facility Expansion

1st September 2020 Highlights • Small scale GMP manufacturing suites open in Q3 2020 • 500L tech transfer and process development site aim for open Q4 2020 • This precedes the next phase with Luina planning to commission a 10,000m2 late phase clinical and commercial production facility targeting late 2021 • New facilities capture more of the global value chain supporting technically advanced microbiome projects • New expanded capacity for bacterial and yeast recombinant projects including vaccine manufacturing including COVID-19 candidates
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement